Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1136/thoraxjnl-2012-202969

Type

Journal article

Journal

Thorax

Publication Date

01/2013

Volume

68

Pages

7 - 8

Keywords

Administration, Inhalation, Adolescent, Adult, Age Factors, Anti-Asthmatic Agents, Antibodies, Anti-Idiotypic, Antibodies, Monoclonal, Humanized, Asthma, Child, Female, Guideline Adherence, Humans, Male, Omalizumab, Practice Guidelines as Topic, Risk Assessment, Severity of Illness Index, Treatment Outcome, United Kingdom, Young Adult